Evoke Pharma Reports First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Evoke Pharma (EVOK) Misses Q1 EPS by 4c
May 11, 2016 4:57 PM EDTEvoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).
As of March 31, 2016, the Companys cash and cash equivalents were approximately $6.1 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
... More